Ods with a positive tpr conclusion, not subject to a conditional approval, and approved without requering a pass would be more likely to be reimbursed in spain

HIGHLIGHTS

• who: Josu00e9 Luis Poveda from the Orphan drugs, Regulatory Variables, Pricing, Reimbursement, Spain have published the article: ODs with a positive TPR conclusion, not subject to a conditional approval, and approved without requering a pass would be more likely to be reimbursed in Spain, in the Journal: (JOURNAL)
• what: This study aims to assess clinical and regulatory variables that would influence pricing and of survival-related outcomes safety profile type of population conditional approval status granted by the European Medicines Agency (EMA) and a positive Therapeutic Positioning Report (TPR) opinion. As a next step of . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.